| MODULE NAME: | Gabapentinoids |
|---|
| MODULE CODE: | L3.3 - 4 |
|---|
| COURSE NAME: | PRESCRIBER AND DISPENSER TRAINING |
|---|
| LEARNING LEVEL: | Level 3 - AOD Treatment Specific Practice |
|---|
| TARGET AUDIENCE: | All prescribers and dispensers. |
|---|
| MODULE TYPE: | Elective |
|---|
| MODULE AIM: | This module will provide health practitioners with an in-depth understanding of the gabapentinoids (pregabalin and gabapentin), their evidence in practice, and some pragmatic approaches to improve the quality use of these agents. |
|---|
| LEARNING OUTCOMES: | By the end of this module, learners will be able to: - Summarise the evidence for gabapentinoids across various pain conditions.
- Summarise the evidence for off-label use of gabapentinoids.
- Apply pharmaceutical knowledge and rational prescribing principles to ensure safe prescribing of gabapentinoids.
- Apply pharmaceutical knowledge and rational prescribing principles to ensure safe cessation of gabapentinoids.
- Demonstrate appropriate management of patients prescribed gabapentinoids including monitoring for adverse effects.
|
|---|
| LENGTH: | 1 hour |
|---|
| CPD: | This module is accredited for: - 0.5 hours of Educational Activities and 0.5 hours of Reviewing Performance with RACGP;
- 1 hours of CPD with ACRRM; and
- 1 hours of Group 1 CPD (or 1 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 1 hours of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities with APC.
Please refer to your Statement of Completion for full details. NB: Insight uploads CPD hours quarterly to ACRRM and RACGP. |
|---|
| REFERENCE LIST: | Available here |
|---|
| LAST UPDATED: | February 2023 |
|---|